-
Annexin A: Cell Death, Inflammation, and Translational Medicine
26 Apr 2025 05:08 GMT
… primarily cancer. In breast cancer, Annexin A9 downregulation … containing liposomes encapsulating Avastin for topical ocular … tetramethoxystilbene in human breast cancer cells. Biomolecules Ther … S100A4 and promotes breast cancer progression through modulating …
-
Adding Bevacizumab to Vinorelbine, Platinum-Based Chemotherapy Improves Outcomes for Patients with HER2- Metastatic Breast Cancer
28 Feb 2025 20:39 GMT
The addition of bevacizumab (Avastin; Roche) to the vinorelbine (Navelbine; … receptor 2-negative (HER2–) metastatic breast cancer (MBC) in a retrospective cohort … heavily pretreated HER2-negative metastatic breast cancer. J Cancer. February 11, 2025 …
-
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 64, Status: Authorised
24 Feb 2025 17:14 GMT
… chemotherapy alone.
Breast cancer
In metastatic breast cancer, Avastin has been shown … recurrent lung cancer, Avastin plus platinum-based chemotherapy … and peritoneal cancer, Avastin, in combination with … : three studies with Avastin in recurrent ovarian, …
-
Celltrion's Vegzelma Tops European Market for Cancer Treatment, Surpassing Avastin
05 Feb 2025 02:12 GMT
… treatment for metastatic colorectal and breast cancer in Europe, marking a significant … share, surpassing the original drug, Avastin, within just two years of …
-
CDER Staff Member Shares Her Experience in a Breast Cancer Clinical Trial
23 Oct 2024 18:05 GMT
… and Dentistry, received a breast cancer diagnosis on Friday, March … she had triple-negative breast cancer, which can be … Avastin for 10 months. Strother had many therapies for her breast cancer … die from triple-negative breast cancer,” Strother says. “I …
-
FDA approves ribociclib with an aromatase inhibitor and ribociclib and letrozole co-pack for early high-risk breast cancer
17 Sep 2024 18:36 GMT
… for metastatic HER2-positive breast cancer
Food and Drug … or metastatic triple negative breast cancer
Food and Drug … with bevacizumab (TECENTRIQ and AVASTIN, Genentech Inc.) for patients … or metastatic HER2-positive breast cancer, including patients with brain …
-
NAFDAC warns public against circulating counterfeit Phesgo, Avastin cancer drugs in Nigeria
03 Jan 2025 10:30 GMT
… drugs Phesgo® 600mg and Avastin 400mg/16ml currently … is used to treat breast cancer. It works by killing … CH-4303, Kaiseraugst, Switzerland.
Avastin 400mg counterfeit details
NAFDAC … raised concerns about counterfeit Avastin 400mg/16ml discovered …
-
Novel Injection Earns FDA ODD in Breast Cancer Brain Metastases
03 Apr 2024 20:45 GMT
… etoposide and bevacizumab (Avastin), leading to a … those with triple-negative breast cancer brain metastases. Previously, … treatment, previously treated breast cancer brain metastases that have … bevacizumab for advanced breast cancer with brain metastases. …
-
AstraZeneca’s AKT Inhibitor Wins FDA Approval for Combo Breast Cancer Treatment
17 Nov 2023 19:51 GMT
… locally advanced or metastatic breast cancer.
According to AstraZeneca, … to reshape treatment for breast cancer patients” with specific biomarker … Truqap to the many breast cancer patients who can … Imfinzi and Genentech’s Avastin showed positive survival …
-
FDA Approves Bevacizumab Biosimilar for Various Cancer Types
11 Apr 2025 18:41 GMT
… a biosimilar referencing bevacizumab (Avastin; Genentech) for the … sixth approved biosimilar for Avastin, Jobevne joins Mvasi … treatment of HER2-positive breast cancer and pegfilgrastim-jmdb ( … chemotherapy.1
REFERENCES
2. Avastin. Import Safety Information …
About
© 1995-2025